中國神華(01088.HK)2019年煤炭銷售量略降3.0%至4.471億噸
格隆匯1月19日丨中國神華(01088.HK)披露2019年12月份主要運營數據,2019年12月,公司商品煤產量同比下降4.3%至2420萬噸,煤炭銷售量同比增長0.2%至4390萬噸;總髮電量同比下降47.2%至142億千瓦時,總售電量同比下降46.9%至133.4億千瓦時。
2019年1-12月,公司商品煤產量同比下降4.7%至2.827億噸,煤炭銷售量同比下降3.0%至4.471億噸;總髮電量同比下降46.2%至1535.5億千瓦時,總售電量同比下降46.2%至1440.4億千瓦時。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.